- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Event 223 results
Webinar
сентября 9, 2021
14th Annual King & Spalding Medical Device Summit
Webinar
июля 28, 2021
COVID-Related Litigation and the PREP Act: A Year Later
Webinar
июля 20, 2021
What Providers Need to Know about the No Surprises Act Interim Final Rules Issued on July 1, 2021
Webinar
июня 22, 2021
Ransomware Attacks and Force Majeure(?)
Webinar
июня 16, 2021
8th Annual Cybersecurity & Privacy Summit
Webinar
июня 15, 2021
Real-World Evidence: The Evolving Landscape for FDA and EU Decision-Making About Drugs, Biologics, and Medical Devices
Webinar
июня 9, 2021
Managing Workforce Diversity, Equity & Inclusion in Technology
Webinar
мая 20, 2021
Practical Steps to Prepare Your Hospital’s Controlled Substances Diversion Program for Government Scrutiny
Webinar
мая 12, 2021
Personal Jurisdiction Over Life Science Businesses In Light of Recent Supreme Court Decisions
Webinar
мая 5, 2021
The Biden Administration’s First 100 Days: An Analysis of Key Developments in International Trade